These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7211590)

  • 1. [Studies on disturbances in the blood-retinal barrier. 1. A trial to measure the fluorescein concentration in the vitreous (author's transl)].
    Ichikawa H; Ando F; Yasuma T; Goto S; Ohzu H
    Nippon Ganka Gakkai Zasshi; 1980 Aug; 84(8):736-44. PubMed ID: 7211590
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early breakdown of the blood-retinal barrier in diabetes.
    Cunha-Vaz J; Faria de Abreu JR; Campos AJ
    Br J Ophthalmol; 1975 Nov; 59(11):649-56. PubMed ID: 1203221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Am J Ophthalmol; 1978 Oct; 86(4):467-73. PubMed ID: 707592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-retinal barrier permeability in diabetic patients.
    Krogsaa B; Lund-Andersen H; Mehlsen J; Sestoft L; Larsen J
    Acta Ophthalmol (Copenh); 1981 Oct; 59(5):689-94. PubMed ID: 7315223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculation of the permeability of the blood-retinal barrier to fluorescein.
    Lund-Andersen H; Krogsaa B; Larsen J
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):173-6. PubMed ID: 3979839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous fluorophotometry in juvenile diabetes.
    Kernell A; Larsson Y; Ludvigsson J; Tenland T
    Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluorescein ERG and vitreous fluorophotometry].
    Tamai M; Mizuno K
    Nippon Ganka Gakkai Zasshi; 1984 Aug; 88(8):1124-7. PubMed ID: 6507190
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structural and functional disorders of transcapillary metabolism if retina in patients with diabetic retinopathy].
    Sorokin EL; Smoliakova GP
    Vestn Oftalmol; 1997; 113(2):16-9. PubMed ID: 9229896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous fluorophotometry evaluation of xenon photocoagulation.
    Noth JM; Vygantas C; Cunha-Vaz JG
    Invest Ophthalmol Vis Sci; 1978 Dec; 17(12):1206-9. PubMed ID: 721394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous fluorophotometry in diabetes mellitus.
    Krupin T; Waltman SR; Becker B
    Ophthalmology; 1979 Jan; 86(1):137-41. PubMed ID: 119199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Staining of cone outer segment and rod outer segment renewal by injecting fluorescent dye, Procion Yellow, into the vitreous (author's transl)].
    Imai K
    Nippon Ganka Gakkai Zasshi; 1980; 84(3):201-5. PubMed ID: 6966886
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitreous variation in vitreous fluorophotometry.
    Ross S; Arffa R; Miller D; Weiss JN; Ransil BJ
    Ann Ophthalmol; 1982 Mar; 14(3):245-9. PubMed ID: 7092034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Permeability of the blood-ocular barrier in diabetics without retinopathy].
    Yoshida A; Kojima M; Nara Y; Ohta I
    Nippon Ganka Gakkai Zasshi; 1988 Jun; 92(6):1016-20. PubMed ID: 3189073
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
    Krupin T; Waltman SR
    Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The aqueous humor-vitreous body barrier and the blood-aqueous humor barrier after YAG laser capsulotomy in capsular sac vs ciliary sulcus fixation of the intraocular lens].
    Schalnus RW; Ohrloff C; Magone T
    Ophthalmologe; 1995 Jun; 92(3):289-92. PubMed ID: 7655200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.